Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20730 | 387 | 32.7 | 68% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1613 | 6524 | TOXICOGENOMICS//BENCHMARK DOSE//GENOTOXIC IMPURITIES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RASH2 MICE | Author keyword | 25 | 77% | 4% | 17 |
| 2 | RASH2 MOUSE | Author keyword | 24 | 82% | 4% | 14 |
| 3 | TGAC | Author keyword | 10 | 61% | 3% | 11 |
| 4 | CARCINOGENICITY TESTING | Author keyword | 10 | 46% | 4% | 16 |
| 5 | TGAC MICE | Author keyword | 8 | 100% | 1% | 5 |
| 6 | ENVIRONM CARCINOGENESIS MUTAGENESIS | Address | 8 | 31% | 5% | 21 |
| 7 | RASH2 | Author keyword | 8 | 62% | 2% | 8 |
| 8 | ZETA GLOBIN | Author keyword | 5 | 50% | 2% | 7 |
| 9 | TOXICOL SAFETY ASSESSMENT | Address | 4 | 35% | 2% | 9 |
| 10 | 26 WEEK CARCINOGENICITY STUDY | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RASH2 MICE | 25 | 77% | 4% | 17 | Search RASH2+MICE | Search RASH2+MICE |
| 2 | RASH2 MOUSE | 24 | 82% | 4% | 14 | Search RASH2+MOUSE | Search RASH2+MOUSE |
| 3 | TGAC | 10 | 61% | 3% | 11 | Search TGAC | Search TGAC |
| 4 | CARCINOGENICITY TESTING | 10 | 46% | 4% | 16 | Search CARCINOGENICITY+TESTING | Search CARCINOGENICITY+TESTING |
| 5 | TGAC MICE | 8 | 100% | 1% | 5 | Search TGAC+MICE | Search TGAC+MICE |
| 6 | RASH2 | 8 | 62% | 2% | 8 | Search RASH2 | Search RASH2 |
| 7 | ZETA GLOBIN | 5 | 50% | 2% | 7 | Search ZETA+GLOBIN | Search ZETA+GLOBIN |
| 8 | 26 WEEK CARCINOGENICITY STUDY | 3 | 100% | 1% | 3 | Search 26+WEEK+CARCINOGENICITY+STUDY | Search 26+WEEK+CARCINOGENICITY+STUDY |
| 9 | 26 WEEKS | 3 | 100% | 1% | 3 | Search 26+WEEKS | Search 26+WEEKS |
| 10 | ALTERNATIVE CARCINOGEN BIOASSAY | 3 | 100% | 1% | 3 | Search ALTERNATIVE+CARCINOGEN+BIOASSAY | Search ALTERNATIVE+CARCINOGEN+BIOASSAY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SHORT TERM CARCINOGENICITY | 23 | 86% | 3% | 12 |
| 2 | PAPILLOMA DEVELOPMENT | 15 | 73% | 3% | 11 |
| 3 | IDENTIFYING CARCINOGENS | 8 | 70% | 2% | 7 |
| 4 | HA RAS GENE | 7 | 25% | 7% | 26 |
| 5 | HETEROZYGOUS P53 DEFICIENT | 4 | 67% | 1% | 4 |
| 6 | AVAILABLE DATA | 4 | 27% | 4% | 14 |
| 7 | CENTER DOT AC | 4 | 75% | 1% | 3 |
| 8 | TGAC MICE | 4 | 56% | 1% | 5 |
| 9 | DEFICIENT XPA | 2 | 67% | 1% | 2 |
| 10 | INDUCED TUMORIGENESIS | 2 | 13% | 4% | 15 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The role of transgenic mouse models in carcinogen identification | 2003 | 71 | 67 | 52% |
| The use of genetically modified mice in cancer risk assessment: Challenges and limitations | 2013 | 2 | 97 | 64% |
| Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review | 2005 | 17 | 81 | 43% |
| A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products (ATMPs) | 2013 | 1 | 5 | 60% |
| Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment | 2000 | 42 | 106 | 30% |
| Mouse skin models for carcinogenic hazard identification: Utilities and challenges | 2007 | 6 | 37 | 51% |
| High susceptibility of human c-Ha-ras protooncogene transgenic rats to carcinogenesis: A cancer-prone animal model | 2005 | 17 | 60 | 23% |
| Genetically engineered animals in drug discovery and development: A maturing resource for toxicologic research | 2004 | 17 | 55 | 29% |
| The US National Toxicology Program evaluation of transgenic mice as predictive models for identifying carcinogens | 1998 | 21 | 6 | 50% |
| Models of breast cancer: quo vadis, animal modeling? | 2004 | 22 | 55 | 20% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENVIRONM CARCINOGENESIS MUTAGENESIS | 8 | 31% | 5.4% | 21 |
| 2 | TOXICOL SAFETY ASSESSMENT | 4 | 35% | 2.3% | 9 |
| 3 | OFF TESTING OFF PHARMACEUT SCI | 2 | 67% | 0.5% | 2 |
| 4 | TRANSGEN CARCINOGENESIS UNIT | 2 | 67% | 0.5% | 2 |
| 5 | EXPT PATHOL CHEMOTHER Y | 1 | 11% | 2.3% | 9 |
| 6 | BIOANALYT DRUG METAB | 1 | 21% | 1.0% | 4 |
| 7 | PRECLIN ASSESSMENT GRP | 1 | 33% | 0.5% | 2 |
| 8 | BIOL SAFETY SETAGAYA KU | 1 | 50% | 0.3% | 1 |
| 9 | ENVIRONM BIOL MED PROGRAM | 1 | 50% | 0.3% | 1 |
| 10 | GOOD PRACTICE | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000195908 | HA RAS//MIHALY PEKAR MED LIFE SCI LIB//HISTOL PATHOL ANAT SECT |
| 2 | 0.0000162443 | HISTORICAL CONTROL DATA//EOSINOPHILIC SUBSTANCE//HYALINE GLOMERULOPATHY |
| 3 | 0.0000138268 | TD50//MC4PC//RODENT CARCINOGENICITY BIOASSAY |
| 4 | 0.0000081854 | LACI//MUTA TM MOUSE//LACL |
| 5 | 0.0000074782 | TOXICOGENOMICS//TOXICOGENOM INFORMAT PROJECT//HAZCHEM |
| 6 | 0.0000071079 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
| 7 | 0.0000069648 | MOVEMENT ACTIVITY//PIPERONYL BUTOXIDE//CYP1A INDUCER |
| 8 | 0.0000063913 | 1 METHYL 1 NITROSOUREA//MAMMARY DYSPLASIA//BREAST DIFFERENTIATION |
| 9 | 0.0000060701 | P53 GENE//P53 MUTANTS//MUTANT P53 |
| 10 | 0.0000057874 | MOUSE LYMPHOMA ASSAY//DGRT//L5178Y MOUSE LYMPHOMA CELL |